Share

July 11, 2006; 67 (1) Views & Reviews

Neuroprotective agents for clinical trials in ALS

A systematic assessment

B. J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O’Neill, S. C. Fagan, M. E. Cudkowicz
First published July 10, 2006, DOI: https://doi.org/10.1212/01.wnl.0000223353.34006.54
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2978

Share

Article Information

vol. 67 no. 1 20-27
DOI: 
https://doi.org/10.1212/01.wnl.0000223353.34006.54
PubMed: 
16832072
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 10, 2006.
Copyright & Usage: 
© 2006

Author Disclosures

    1. B. J. Traynor, MD, MRCPI,
    2. L. Bruijn, PhD,
    3. R. Conwit, MD,
    4. F. Beal, MD,
    5. G. O’Neill, MD, MRCPI,
    6. S. C. Fagan, PharmD, FCCP and
    7. M. E. Cudkowicz, MD, MSc
  1. B. J. Traynor, MD, MRCPI,
  2. L. Bruijn, PhD,
  3. R. Conwit, MD,
  4. F. Beal, MD,
  5. G. O’Neill, MD, MRCPI,
  6. S. C. Fagan, PharmD, FCCP and
  7. M. E. Cudkowicz, MD, MSc
  1. From the Neurology Clinical Trials Unit (B.J.T., M.E.C.), Department of Neurology, Massachusetts General Hospital, Boston; The ALS Association (L.B.), Palm Harbor, FL; National Institute of Neurological Diseases and Stroke (NINDS) (R.C.), Bethesda, MD; Department of Neurology (F.B.), Weill Medical College of Cornell University, New York, NY; Biogen Idec Inc. (G.O.), Cambridge, MA; and University of Georgia College of Pharmacy and Medical College of Georgia (S.C.F.), Augusta.
  1. Address correspondence and reprint requests to Dr. Bryan J. Traynor, SDGE, NIMH, Building 35, Room 1A110, 35 Convent Drive, Bethesda, MD 20892-3720; e-mail: traynorb{at}mail.nih.gov
View Full Text

Article usage

Article usage: July 2006 to December 2022

AbstractFullPdfSource
Jul 2006514206323Highwire
Aug 2006161196202Highwire
Sep 2006198126128Highwire
Oct 20061627689Highwire
Nov 20061589094Highwire
Dec 20061016571Highwire
Jan 20071338296Highwire
Feb 20071157869Highwire
Mar 20071087167Highwire
Apr 20071248269Highwire
May 20071196366Highwire
Jun 2007835564Highwire
Jul 2007894649Highwire
Aug 2007874342Highwire
Sep 2007724142Highwire
Oct 2007816148Highwire
Nov 20071164043Highwire
Dec 2007743937Highwire
Jan 2008796856Highwire
Feb 2008682828Highwire
Mar 2008833445Highwire
Apr 20081074342Highwire
May 2008723828Highwire
Jun 2008744936Highwire
Jul 2008963226Highwire
Aug 2008772122Highwire
Sep 2008853240Highwire
Oct 2008902732Highwire
Nov 20081053944Highwire
Dec 2008742622Highwire
Jan 2009702724Highwire
Feb 2009523026Highwire
Mar 2009763741Highwire
Apr 2009862117Highwire
May 2009532420Highwire
Jun 2009531315Highwire
Jul 200963710Highwire
Aug 2009501113Highwire
Sep 2009602118Highwire
Oct 2009562419Highwire
Nov 2009671524Highwire
Dec 200961912Highwire
Jan 2010601618Highwire
Feb 2010762020Highwire
Mar 2010721313Highwire
Apr 2010571013Highwire
May 2010451313Highwire
Jun 2010631116Highwire
Jul 201074129Highwire
Aug 2010531116Highwire
Sep 2010621112Highwire
Oct 2010491619Highwire
Nov 20102223Highwire
Dec 20105699Highwire
Jan 20115189Highwire
Feb 20114765Highwire
Mar 20116676Highwire
Apr 2011561613Highwire
May 20114899Highwire
Jun 2011421114Highwire
Jul 201147104Highwire
Aug 20113952Highwire
Sep 201148137Highwire
Oct 2011551114Highwire
Nov 20116054Highwire
Dec 20115021Highwire
Jan 20124556Highwire
Feb 20125348Highwire
Mar 20125167Highwire
Apr 20124666Highwire
May 20127737Highwire
Jun 20125165Highwire
Jul 20124078Highwire
Aug 20122055Highwire
Sep 20123754Highwire
Oct 20123452Highwire
Nov 20124078Highwire
Dec 20124486Highwire
Jan 20134522Highwire
Feb 20134122Highwire
Mar 20136115Highwire
Apr 20137047Highwire
May 20133612Highwire
Jun 20132822Highwire
Jul 20134241Highwire
Aug 20132523Highwire
Sep 20134021Highwire
Oct 20134712Highwire
Nov 20135246Highwire
Dec 20134311Highwire
Jan 20144372Highwire
Feb 20142933Highwire
Mar 20142844Highwire
Apr 20143667Highwire
May 20143865Highwire
Jun 20142512Highwire
Jul 20145131Highwire
Aug 20144633Highwire
Sep 20142911Highwire
Oct 20143913Highwire
Nov 20145654Highwire
Dec 20146643Highwire
Jan 20154834Highwire
Feb 20154123Highwire
Mar 20153641Highwire
Apr 20153611Highwire
May 20152621Highwire
Jun 20152732Highwire
Jul 20152242Highwire
Aug 20152143Highwire
Sep 20151676Highwire
Oct 20154242Highwire
Nov 20154111Highwire
Dec 20153556Highwire
Jan 20164452Highwire
Feb 20164300Highwire
Mar 20167854Highwire
Apr 20163412Highwire
May 20163612Highwire
Jun 20164242Highwire
Jul 20163622Highwire
Aug 20163420Highwire
Sep 20165021Highwire
Oct 20166031Highwire
Nov 20164114Highwire
Dec 20163722Highwire
Jan 20173933Highwire
Feb 20174312Highwire
Mar 20172411Highwire
Apr 20172911Highwire
May 20175181Highwire
Jun 20175011Highwire
Jul 20172900Highwire
Aug 20171903Highwire
Sep 20172700Highwire
Oct 20173912Highwire
Nov 20172920Highwire
Dec 20174821Highwire
Jan 20185710Highwire
Feb 20184542Highwire
Mar 20188020Highwire
Apr 20186021Highwire
May 20185700Highwire
Jun 20184432Highwire
Jul 20184211Highwire
Aug 20182623Highwire
Sep 20182222Highwire
Oct 20183001Highwire
Nov 20184311Highwire
Dec 20184510Highwire
Jan 20196521Highwire
Feb 20194903Highwire
Mar 20192901Highwire
Apr 20192312Highwire
May 20193522Highwire
Jun 20192102Highwire
Jul 20194454Highwire
Aug 20192345Highwire
Sep 20195513Highwire
Oct 20196006Highwire
Nov 201954311Highwire
Dec 20193117Highwire
Jan 20206018Highwire
Feb 20204817Highwire
Mar 20202824Highwire
Apr 20203929Highwire
May 20205216Highwire
Jun 20203801Highwire
Jul 20203822Highwire
Aug 20204715Highwire
Sep 202084415Highwire
Oct 20209728Highwire
Nov 202081625Highwire
Dec 202071327Highwire
Jan 202167213Highwire
Feb 20214069Highwire
Mar 20214420Highwire
Apr 20215000Highwire
May 20215800Highwire
Jun 20213100Highwire
Jul 20214603Highwire
Aug 20217609Highwire
Sep 20214726Highwire
Oct 20214424Highwire
Nov 202171311Highwire
Dec 20214514Highwire
Jan 20226916Highwire
Feb 20224732Highwire
Mar 20229515Highwire
Apr 20224111Highwire
May 20226022Highwire
Jun 20223300Highwire
Jul 20223301Highwire
Aug 20224100Highwire
Sep 20225140Highwire
Oct 20227232Highwire
Nov 20225531Highwire
Dec 20223021Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Alert Me